P. Weisweiler

P. Schwandt, P. Weisweiler, B. Schottdorf, 1979, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Determination of cholesterol and phospholipid concentrations in high-density lipoproteins by heparin-manganese chloride precipitation.

P. Schwandt, P. Weisweiler, 1979, Clinica chimica acta; international journal of clinical chemistry.

Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.

V. Armstrong, F. Beil, H. Greten, 1994, The American journal of medicine.

High density lipoproteins unaffected by dietary fat modification.

P. Schwandt, P. Weisweiler, P. Janetschek, 1982, Atherosclerosis.

Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: A controlled long‐term comparative trial

P. Schwandt, M. Middeke, H. Holzgreve, 1987, Clinical cardiology.

Fat restriction alters the composition of apolipoprotein B-100 containing very low-density lipoproteins in humans.

P. Schwandt, P. Weisweiler, P. Janetschek, 1986, The American journal of clinical nutrition.

High-density lipoprotein subfractions after a short term fast.

P. Schwandt, P. Weisweiler, 1981, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Serum lipoprotein lipids after gemfibrozil treatment.

P. Schwandt, P. Weisweiler, G. Neureuther, 1979, Artery.

Obesity and Lipoproteins

P. Weisweiler, 1990 .

Obesity and Lipoproteins Influence of Weight Reduction in Postmenopausal Women

P. Weisweiler, 1990 .

Plasma lipoproteins and lipase and lecithin:cholesterol acyltransferase activities in obese subjects before and after weight reduction.

P. Weisweiler, Peter Weisweiler, 1987, The Journal of clinical endocrinology and metabolism.

The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.

P. Schwandt, P. Weisweiler, 1980, Atherosclerosis.

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome.

W. Caselmann, P. Weisweiler, D. Jüngst, 1987, Clinica chimica acta; international journal of clinical chemistry.

[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].

P. Schwandt, P. Weisweiler, 1977, Klinische Wochenschrift.

Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus

P. Schwandt, P. Weisweiler, M. Drosner, 1982, Diabetologia.

Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.

P. Schwandt, W. Merk, P. Weisweiler, 1984, Atherosclerosis.

Simvastatin and bezafibrate: Effects on serum lipoproteins and lecithin: Cholesterol acyltransferase activity in familial hypercholesterolaemia

P. Weisweiler, 2004, European Journal of Clinical Pharmacology.

Changes in serum lipoproteins and in lecithin: cholesterol acyltransferase activity with dietary fat modification.

P. Schwandt, P. Weisweiler, 1987, Advances in experimental medicine and biology.

Changes in very low and low density lipoproteins with dietary fat modification.

P. Schwandt, P. Weisweiler, M. Drosner, 1983, Atherosclerosis.

Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.

P. Schwandt, P. Weisweiler, V. Heinemann, 1984, International journal of clinical pharmacology, therapy, and toxicology.

Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography.

P. Weisweiler, 1987, Clinica chimica acta; international journal of clinical chemistry.

Quantitation of Apolipoprotein E-Isoforms in Diabetes Mellitus

P. Schwandt, P. Weisweiler, D. Jüngst, 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.

P. Schwandt, P. Weisweiler, 1980, Artery.

Determination of high-density lipoproteins: comparison of HDL-cholesterol, HDL-phospholipids, and HDL-apolipoprotein A-I.

P. Schwandt, P. Weisweiler, B. Sperl, 1981, Clinical chemistry.

Separation of apolipoprotein B subfractions by high performance gel permeation chromatography.

P. Schwandt, W. Richter, P. Weisweiler, 1986, Clinica chimica acta; international journal of clinical chemistry.

The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.

P. Schwandt, P. Weisweiler, G. Neureuther, 1979, Atherosclerosis.

Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.

P. Schwandt, W. Richter, P. Weisweiler, 1982, Atherosclerosis.

Course of acute viral hepatitis B during immune prevention

P. Schwandt, W. Richter, P. Weisweiler, 1981 .

Isolation and quantification of apolipoproteins C-I, C-II, and C-III0-2 in very-low-density lipoproteins by "high-performance" anion-exchange chromatography.

P. Schwandt, P. Weisweiler, C. Friedl, 1986, Clinical chemistry.

Isolation of human apolipoprotein E by chromatofocusing.

P. Schwandt, P. Weisweiler, 1982, Clinica chimica acta; international journal of clinical chemistry.

Determination of Human Apolipoproteins A-I, B, and E by Laser Nephelometry

P. Schwandt, P. Weisweiler, 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Immunonephelometric Quantitation of Apolipoprotein E in Human Serum

P. Schwandt, P. Weisweiler, 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[Giant-cell arteritis].

P. Weisweiler, P. Meister, H. Tuczek, 1975, Die Medizinische Welt.

Separation of human C-apolipoproteins by high-performance liquid chromatography.

P. Schwandt, W. Richter, P. Weisweiler, 1981, Journal of chromatography.

Simvastatin plus low-dose colestipol in the treatment of severe familial hypercholesterolemia

P. Weisweiler, 1988 .

Chacterization of human apolipoprotein A-I by reversed-phase high-performance liquid chromatography

P. Schwandt, W. Richter, P. Weisweiler, 1985 .

Biological ACTH Activity of Lipid Mobilizing Peptide Fractions from Hog Pituitaries*

P. Scriba, P. Schwandt, P. Weisweiler, 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Preparation of lipid mobilizing peptide B from pig pituitaries by acrylamide gel electrophoresis.

P. Schwandt, P. Weisweiler, H. Ruschewski, 1973, Acta endocrinologica. Supplementum.

Lipolytic action of porcine TSH caused by lipotropin contamination?

P. Schwandt, P. Weisweiler, 1973, Acta endocrinologica. Supplementum.

[Lipid mobilizing effect of a pituitary gland peptide in pigs of different species].

H. Doerr, P. Schwandt, P. Weisweiler, 1971, Klinische Wochenschrift.

Immunochemical determination of apolipoprotein a I in human serum

P. Schwandt, P. Weisweiler, 1980 .